Nassiri S, Ahmadi Afshar N, Almasi P
Stem Cell Res Ther. 2023; 14(1):282.
PMID: 37794439
PMC: 10552299.
DOI: 10.1186/s13287-023-03504-3.
Wang X, Feng Y, Zhou S, Yang X, Liu Y, Peng Q
Lab Invest. 2021; 101(12):1618-1626.
PMID: 34376779
DOI: 10.1038/s41374-021-00648-9.
Moaaz M, Lotfy H, Elsherbini B, Motawea M, Fadali G
Asian Pac J Cancer Prev. 2020; 21(11):3393-3403.
PMID: 33247701
PMC: 8033108.
DOI: 10.31557/APJCP.2020.21.11.3393.
Safarzadeh E, Asadzadeh Z, Safaei S, Hatefi A, Derakhshani A, Giovannelli F
Front Immunol. 2020; 11:572323.
PMID: 33133086
PMC: 7562789.
DOI: 10.3389/fimmu.2020.572323.
Ren W, Xi G, Li X, Zhao L, Yang K, Fan X
Mol Cell Biochem. 2020; 476(1):471-482.
PMID: 32996080
DOI: 10.1007/s11010-020-03923-3.
Immunological and classical subtypes of oral premalignant lesions.
Foy J, Bertolus C, Ortiz-Cuaran S, Albaret M, Williams W, Lang W
Oncoimmunology. 2018; 7(12):e1496880.
PMID: 30524889
PMC: 6279331.
DOI: 10.1080/2162402X.2018.1496880.
Transcriptional activation of the miR-17-92 cluster is involved in the growth-promoting effects of MYB in human Ph-positive leukemia cells.
Spagnuolo M, Regazzo G, De Dominici M, Sacconi A, Pelosi A, Korita E
Haematologica. 2018; 104(1):82-92.
PMID: 30076175
PMC: 6312025.
DOI: 10.3324/haematol.2018.191213.
MiR-34a promotes DCs development and inhibits their function on T cell activation by targeting WNT1.
Huang A, Yang Y, Chen S, Xia F, Sun D, Fang D
Oncotarget. 2017; 8(10):17191-17201.
PMID: 28199987
PMC: 5370032.
DOI: 10.18632/oncotarget.15228.
The human nucleophosmin 1 mutation A inhibits myeloid differentiation of leukemia cells by modulating miR-10b.
Zou Q, Tan S, Yang Z, Wang J, Xian J, Zhang S
Oncotarget. 2016; 7(44):71477-71490.
PMID: 27669739
PMC: 5342094.
DOI: 10.18632/oncotarget.12216.
miRNA in Macrophage Development and Function.
Roy S
Antioxid Redox Signal. 2016; 25(15):795-804.
PMID: 27353423
PMC: 5107671.
DOI: 10.1089/ars.2016.6728.
MiR-146 and miR-125 in the regulation of innate immunity and inflammation.
Lee H, Kim T, Jo E
BMB Rep. 2016; 49(6):311-8.
PMID: 26996343
PMC: 5070718.
DOI: 10.5483/bmbrep.2016.49.6.056.
MicroRNA Cargo of Extracellular Vesicles from Alcohol-exposed Monocytes Signals Naive Monocytes to Differentiate into M2 Macrophages.
Saha B, Momen-Heravi F, Kodys K, Szabo G
J Biol Chem. 2015; 291(1):149-59.
PMID: 26527689
PMC: 4697152.
DOI: 10.1074/jbc.M115.694133.
Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
Parker K, Beury D, Ostrand-Rosenberg S
Adv Cancer Res. 2015; 128:95-139.
PMID: 26216631
PMC: 4662416.
DOI: 10.1016/bs.acr.2015.04.002.
PU.1-Regulated Long Noncoding RNA lnc-MC Controls Human Monocyte/Macrophage Differentiation through Interaction with MicroRNA 199a-5p.
Chen M, Lin H, Shen C, Ma Y, Wang F, Zhao H
Mol Cell Biol. 2015; 35(18):3212-24.
PMID: 26149389
PMC: 4539372.
DOI: 10.1128/MCB.00429-15.
Regulating Tumor Myeloid-Derived Suppressor Cells by MicroRNAs.
Chen S, Zhang Y, Kuzel T, Zhang B
Cancer Cell Microenviron. 2015; 2(1).
PMID: 26005707
PMC: 4440580.
DOI: 10.14800/ccm.637.
Alcohol-induced miR-27a regulates differentiation and M2 macrophage polarization of normal human monocytes.
Saha B, Bruneau J, Kodys K, Szabo G
J Immunol. 2015; 194(7):3079-87.
PMID: 25716995
PMC: 4517579.
DOI: 10.4049/jimmunol.1402190.
Myeloid-derived microRNAs, miR-223, miR27a, and miR-652, are dominant players in myeloid regulation.
Gilicze A, Wiener Z, Toth S, Buzas E, Pallinger E, Falcone F
Biomed Res Int. 2014; 2014:870267.
PMID: 25177699
PMC: 4142666.
DOI: 10.1155/2014/870267.
Conversion of human fibroblasts into monocyte-like progenitor cells.
Pulecio J, Nivet E, Sancho-Martinez I, Vitaloni M, Guenechea G, Xia Y
Stem Cells. 2014; 32(11):2923-2938.
PMID: 25175072
PMC: 4198469.
DOI: 10.1002/stem.1800.
miR-190b is markedly upregulated in the intestine in response to simian immunodeficiency virus replication and partly regulates myotubularin-related protein-6 expression.
Mohan M, Chandra L, Torben W, Aye P, Alvarez X, Lackner A
J Immunol. 2014; 193(3):1301-13.
PMID: 24981450
PMC: 4108538.
DOI: 10.4049/jimmunol.1303479.
Type I interferons as regulators of human antigen presenting cell functions.
Gessani S, Conti L, Del Corno M, Belardelli F
Toxins (Basel). 2014; 6(6):1696-723.
PMID: 24866026
PMC: 4073125.
DOI: 10.3390/toxins6061696.